Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 15mL

NDC: 24208-735-06

Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 15 mL — Bausch & Lomb

Active ingredients	Cyclopentolate hydrochloride 1% (10 mg/mL)
Dosage form	Ophthalmic solution
Route	Topical ophthalmic
Size	15 mL
Manufacturer	Bausch & Lomb
NDC	24208-735-06

Indications and Usage

Used to produce mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation) for diagnostic ophthalmic procedures.

Dosage and Administration

In adults, instill one or two drops in the eye, which may be repeated in 5 to 10 minutes if needed. In infants and small children, use the lowest effective concentration, apply pressure over the nasolacrimal sac for two to three minutes, and observe closely for at least 30 minutes.

Warnings and Precautions

• Infants and young children are especially susceptible to central nervous system and cardiopulmonary effects
• May cause transient elevation of intraocular pressure
• Caution advised in patients with Down's syndrome
• Psychotic reactions and behavioral disturbances have occurred, particularly in children

Contraindications

Contraindicated in patients hypersensitive to any component of this preparation.

Adverse Reactions

Ocular effects include burning, photophobia, blurred vision, and transient increased intraocular pressure. Systemic effects, more common in children, include psychotic reactions, behavioral disturbances, ataxia, restlessness, and tachycardia.

Storage and Handling

Store between 15°C to 25°C (59°F to 77°F).

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.